二氧化碳作为对比剂常规用于腹主动脉瘤腔内修复术的安全性、有效性及陷阱
本研究回顾性比较了52例二氧化碳引导与49例碘对比剂引导的腹主动脉瘤腔内修复术,两组技术成功率均为100%,术后急性肾损伤发生率低且相似,但二氧化碳组辐射暴露更高(中位311.48 vs 159.86 mGy/cm²,P<0.001)。作者认为二氧化碳引导下EVAR可安全完成且无需碘对比剂,但辐射暴露增加,其肾脏保护作用在标准人群中不明确,在肾功能不全患者中需进一步研究验证。
要点
- 两组技术成功率均为100%,无目标血管意外覆盖。
- 二氧化碳组辐射暴露高于碘对比剂组(中位311.48 vs 159.86 mGy/cm²,P<0.001)。
- 术后急性肾损伤发生率低且两组相似,随访期间两组肾功能均无显著恶化。
核心结论
- 腹主动脉瘤腔内修复术可在二氧化碳引导下安全完成,无需联合任何剂量的碘对比剂,但辐射暴露增加。
- 二氧化碳引导EVAR在标准人群中的肾脏保护作用不明确,其在肾功能不全患者中的作用需在选定人群中进一步研究验证。
研究设计与样本
- 回顾性收集2020年9月至2021年5月在本单位接受二氧化碳引导标准EVAR的所有患者数据,并与2019年12月至2020年8月接受碘对比剂引导EVAR的所有患者数据进行比较。
- 对比剂选择不基于任何术前因素,两个时期所有患者均常规使用相应对比剂。
- 主要终点为技术成功率;次要终点为早期和晚期并发症发生率、辐射暴露及肾功能损害。
- 二氧化碳引导EVAR组52例,碘对比剂引导EVAR组49例。
主要发现
- 技术成功率两组均为100%,无任何目标血管意外覆盖。
- 术中内漏在碘对比剂组为14%,在二氧化碳组为25%。
- 辐射暴露二氧化碳组高于碘对比剂组(中位311.48 vs 159.86 mGy/cm²,P<0.001)。
- 术后急性肾损伤发生率低且两组相似。
- 两组随访期间均未报告肾功能随时间显著恶化。
临床怎么用
- 作者认为EVAR可在二氧化碳引导下安全完成,无需联合任何剂量的碘对比剂,但辐射暴露增加。
- 作者指出二氧化碳引导EVAR在标准人群中的肾脏保护作用不明确,其在肾功能不全患者中的作用需进一步研究验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the evidence of good performance, carbon dioxide (CO2) routine employment as a contrast agent for endovascular procedures is far from being adopted with its use currently limited to patients with renal impairment and known allergy to iodinated contrast medium (ICM). The purpose of our study is to evaluate the safety and effectiveness of CO2 guided endovascular abdominal aortic aneurysm repair (EVAR) in a standard population and to assess the rationale for a future widespread use. METHODS: We retrospectively collected data of every patient who underwent CO2 guided standard EVAR from September 2020 to May 2021 and compared them with the data of every patient who underwent EVAR using ICM from December 2019 to August 2020 in our unit. The selection of the contrast medium was not based on any preoperative factor as the contrast medium was routinely used in every patient in both periods. The primary end point of the study was the technical success rate. Secondary end points were the early and late complication rates, radiation exposure and renal function impairment. RESULTS: 49 patients underwent ICM guided EVAR and 52 patients underwent CO2 guided EVAR in our unit in the time frames specified above. The technical success rate was 100% in both groups with no accidental coverage of any target vessel. Intraoperative endoleaks were observed in 14% of ICM patients and 25% of CO2 patients. The radiation exposure was higher in the CO2 group if compared to the ICM group (311.48 vs. 159.86 median mGy/cm2 - P < 0.001). The incidence of postoperative acute kidney injury was low and similar in the 2 groups. No significant worsening over time of the renal function has been reported in both groups. CONCLUSIONS: EVAR can be safely performed under CO2 guidance without the integration of any quantity of ICM but with an increase in radiation exposure. The nephroprotective role of CO2 guided EVAR in a standard population is unclear and the same role in renal impaired patients should be validated with further studies on selected populations.
引用
- Quaglino S, Ferrero E, Ferri M, et al. Safety, Effectiveness and Pitfalls of Carbon Dioxide Routine Use as a Contrast Agent for Endovascular Abdominal Aortic Repair. Ann Vasc Surg. 2023. PMID: 38110085. doi:10.1016/j.avsg.2023.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。